Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness. // Molecular Therapy Advances. – URL: https://www.sciencedirect.com/science/article/pii/S3117387X26001424?dgcid=rss_sd_all
Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness. Molecular Therapy Advances. https://www.sciencedirect.com/science/article/pii/S3117387X26001424?dgcid=rss_sd_all
“Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.” Molecular Therapy Advances.
@article{article100993,
title = {Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness},
journal = {Molecular Therapy Advances},
url = {https://www.sciencedirect.com/science/article/pii/S3117387X26001424?dgcid=rss_sd_all}
}